Jump to content

Danish vaccine ABNCoV2 in Phase 1 looks promising.


Virt

Recommended Posts

I followed this for quite for time and it looks promising, but i know there are a long way from phase 1 to a finished phase 3 study and releasing a product in the end.

 

The results from phase 1 looks very promising..

 

https://www.investegate.co.uk/bavarian-nordic-a-s/gnw/bavarian-nordic-reports-initial-results-from-first-in-human-trial-of-covid-19-vaccine/20210809060000H0547/

 

Other interviews with one of their scientists Adam Sander Bertelsen shows they have quite high hopes for this vaccine ABNCoV2.

(can't find an english article to link to, because all i can find is in danish. This one in danish if anyone want to use a translator and use it https://dagensmedicin.dk/molekylaer-velcro-er-noeglen-bag-staerkt-immunrespons-i-dansk-covid-19-vaccine/)

 

Their hope is to develop a vaccine that last for life with 1 or 2 shots.

They will not be able to compete with the mRNA vaccines because they are so fast to produce/improve fast, but they hope their vaccine will last a lifetime.

That could be a game changer if someone developed a vaccine that would last forever against covid 19 no matter what mutation surfaced.

 

There is a long way to go, and they still need funding for the phase 3 study, but i really cross my fingers that someone develop a vaccine that last a lifetime.

I really want to get back to a normal life, and if vaccines like this can do the trick, i will be a happy camper.

 

News from their own website and no i don't work for them ????

 

https://www.bavarian-nordic.com/investor/news/news.aspx?news=6374

 

 

  • Like 1
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...